With nearly 4,000 employees and facilities linked across a global network, MDS Pharma Services provides contract research and drug-development support from discovery through late-stage clinical development. Its particularly distinctive reach includes more than 900 Phase I beds worldwide and dedicated centralized cardiac services supported from Paris, Toronto and Singapore. The company also maintains an independent quality-assurance organization spanning its business lines and locations.
The College of American Pathologists (CAP)
certification
Clinical Laboratory Improvement Amendments (CLIA)
certification
New York State
certification
National Glycohemoglobin Standardization Program (NGSP)
certification